Loading...

The Trump Tax Cut and Big Pharma - Hallo friend WELCOME TO AMERICA, In the article you read this time with the title The Trump Tax Cut and Big Pharma, we have prepared well for this article you read and download the information therein. hopefully fill posts Article AMERICA, Article CULTURAL, Article ECONOMIC, Article POLITICAL, Article SECURITY, Article SOCCER, Article SOCIAL, we write this you can understand. Well, happy reading.

Title : The Trump Tax Cut and Big Pharma
link : The Trump Tax Cut and Big Pharma

The Trump Tax Cut and Big Pharma

CEOs of 7 pharmaceutical multinationals addressed the Senate Finance Committee:

Pharma execs offer Senate ideas to lower drug costs – except actually cutting prices. Executives from seven pharmaceutical companies — AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer and Sanofi — are testifying before the Senate Finance Committee. The pharma executives have a number of ideas to reduce drug prices for patients, except lowering list prices. High drug prices has become a rare bipartisan issue, with lawmakers on both sides of the aisle demanding change.

One of these questions posed to the CEO of Abbvie was how much of the benefit from the 2017 tax cut did his company pass onto consumers. I guess the Senator was expecting an honest answer being “none”. But the actual answer came out that AbbVie did not get much benefit from this reduction of corporate profit tax rates. How could that be? Well – look at its past 10-K filings and you will see that AbbVie has sourced little to none of its massive profits to the U.S. parent. Why would you benefit from a tax rate cut when one is engaged in massive transfer pricing manipulation?!

CEOs of 7 pharmaceutical multinationals addressed the Senate Finance Committee:

Pharma execs offer Senate ideas to lower drug costs – except actually cutting prices. Executives from seven pharmaceutical companies — AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer and Sanofi — are testifying before the Senate Finance Committee. The pharma executives have a number of ideas to reduce drug prices for patients, except lowering list prices. High drug prices has become a rare bipartisan

Loading...

issue, with lawmakers on both sides of the aisle demanding change. One of these questions posed to the CEO of Abbvie was how much of the benefit from the 2017 tax cut did his company pass onto consumers. I guess the Senator was expecting an honest answer being “none”. But the actual answer came out that AbbVie did not get much benefit from this reduction of corporate profit tax rates. How could that be? Well – look at its past 10-K filings and you will see that AbbVie has sourced little to none of its massive profits to the U.S. parent. Why would you benefit from a tax rate cut when one is engaged in massive transfer pricing manipulation?!

Thus articles The Trump Tax Cut and Big Pharma

that is all articles The Trump Tax Cut and Big Pharma This time, hopefully can provide benefits to all of you. Okay, see you in another article posting.

You now read the article The Trump Tax Cut and Big Pharma with the link address https://welcometoamerican.blogspot.com/2019/02/the-trump-tax-cut-and-big-pharma.html

Tweet

Subscribe to receive free email updates: